Quantinno Capital Management LP trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 4.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 82,025 shares of the company's stock after selling 3,699 shares during the period. Quantinno Capital Management LP's holdings in Cardinal Health were worth $9,701,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also made changes to their positions in the business. Cyrus J. Lawrence LLC acquired a new position in Cardinal Health during the fourth quarter worth approximately $26,000. Promus Capital LLC purchased a new position in shares of Cardinal Health during the fourth quarter worth approximately $30,000. Bellwether Advisors LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at $32,000. Lee Danner & Bass Inc. purchased a new stake in Cardinal Health in the 4th quarter valued at $35,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in Cardinal Health during the 4th quarter worth $36,000. 87.17% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research analysts have commented on the stock. Mizuho lifted their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research note on Monday, March 31st. Citigroup reaffirmed a "neutral" rating on shares of Cardinal Health in a research note on Thursday, May 1st. StockNews.com upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. Argus set a $148.00 price objective on shares of Cardinal Health in a research report on Tuesday, February 4th. Finally, Morgan Stanley lifted their target price on shares of Cardinal Health from $142.00 to $166.00 and gave the company an "overweight" rating in a report on Monday, May 5th. Four investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $146.43.
Get Our Latest Report on Cardinal Health
Cardinal Health Trading Down 0.6%
NYSE CAH traded down $0.86 on Wednesday, reaching $153.91. The stock had a trading volume of 406,830 shares, compared to its average volume of 2,225,561. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $156.44. The business has a 50 day moving average price of $138.20 and a 200 day moving average price of $128.37. The company has a market capitalization of $36.74 billion, a price-to-earnings ratio of 28.70, a P/E/G ratio of 1.49 and a beta of 0.66.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The company had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. During the same quarter in the prior year, the business posted $2.08 EPS. Cardinal Health's quarterly revenue was up .0% on a year-over-year basis. On average, analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.33%. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio is presently 31.83%.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.